Dr. Perkins is a visionary physician, scientist, and executive who is responsible for leading all clinical and therapeutic operations at the HLI.
Prior to joining HLI, Dr. Perkins was Executive Vice President for Strategy and Innovation, and Chief Transformation Officer at Vanguard Health Systems.
He helped transform Vanguard from a traditional fee for service healthcare model, to a fee for value, “population health” model.
Dr. Perkins began his career at the Centers for Disease Control and Prevention (CDC) in 1989. At the CDC he led some of the most important and high profile programs and published more than 120 peer-reviewed publications and book chapters.
Dr. Perkins co-discovered the bacteria which causes Cat Scratch Diseases and conducted translational research leading to development of several new bacterial meningitis and pneumonia vaccines.
In 2001 Dr. Perkins led the investigations into the anthrax attacks in the United States. In 2005 he was appointed CDC’s Chief Strategy and Innovation Officer. Working closely with the CDC Director, he built a $2 billion state-of-the-art emergency response capability and positioned the improvement of population health as a focus of the healthcare reform movement within the White House administration at that time.
Dr. Perkins received his BA in Microbiology and his MD from the University of Missouri-Columbia, and an MBA from Emory University.
Prior to joining HLI, Dr. Perkins was Executive Vice President for Strategy and Innovation, and Chief Transformation Officer at Vanguard Health Systems.
He helped transform Vanguard from a traditional fee for service healthcare model, to a fee for value, “population health” model.
Dr. Perkins began his career at the Centers for Disease Control and Prevention (CDC) in 1989. At the CDC he led some of the most important and high profile programs and published more than 120 peer-reviewed publications and book chapters.
Dr. Perkins co-discovered the bacteria which causes Cat Scratch Diseases and conducted translational research leading to development of several new bacterial meningitis and pneumonia vaccines.
In 2001 Dr. Perkins led the investigations into the anthrax attacks in the United States. In 2005 he was appointed CDC’s Chief Strategy and Innovation Officer. Working closely with the CDC Director, he built a $2 billion state-of-the-art emergency response capability and positioned the improvement of population health as a focus of the healthcare reform movement within the White House administration at that time.
Dr. Perkins received his BA in Microbiology and his MD from the University of Missouri-Columbia, and an MBA from Emory University.
Sessions
10/02/2016
10.50 - 11.20
Dubai Municipality Hall